Keefe, Bruyette & Woods Lowers Globe Life (NYSE:GL) Price Target to $190.00

Globe Life (NYSE:GL) had its target price decreased by stock analysts at Keefe, Bruyette & Woods from $192.00 to $190.00 in a report released on Friday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Keefe, Bruyette & Woods’ price target points to a potential upside of 10.41% from the stock’s current price.

Several other brokerages have also issued reports on GL. Truist Financial increased their price objective on Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a report on Friday, April 24th. Wells Fargo & Company boosted their target price on Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a research note on Thursday, July 9th. Morgan Stanley upped their target price on Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. JPMorgan Chase & Co. upped their target price on Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research report on Tuesday. Finally, Weiss Ratings downgraded Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $187.40.

Globe Life Stock Up 0.6%

GL traded up $1.00 on Friday, reaching $172.09. 300,326 shares of the company traded hands, compared to its average volume of 558,100. The stock’s 50 day moving average price is $168.70 and its 200-day moving average price is $152.76. Globe Life has a 52-week low of $127.85 and a 52-week high of $191.55. The company has a market cap of $13.36 billion, a price-to-earnings ratio of 11.44 and a beta of 0.47. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07.

Globe Life (NYSE:GL) last issued its earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a net margin of 19.58% and a return on equity of 20.73%. The company had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the business earned $3.05 EPS. The company’s quarterly revenue was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, sell-side analysts expect that Globe Life will post 15.64 EPS for the current fiscal year.

Insider Buying and Selling at Globe Life

In related news, CFO Thomas Peter Kalmbach sold 7,936 shares of the stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $156.59, for a total value of $1,242,698.24. Following the completion of the sale, the chief financial officer directly owned 50,496 shares of the company’s stock, valued at approximately $7,907,168.64. This represents a 13.58% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO James Matthew Darden sold 4,663 shares of the firm’s stock in a transaction dated Tuesday, April 28th. The shares were sold at an average price of $153.88, for a total transaction of $717,542.44. Following the transaction, the chief executive officer directly owned 58,451 shares in the company, valued at $8,994,439.88. The trade was a 7.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 90,187 shares of company stock worth $14,299,874. Company insiders own 2.11% of the company’s stock.

Hedge Funds Weigh In On Globe Life

Several institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its stake in Globe Life by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock worth $1,411,311,000 after purchasing an additional 86,349 shares in the last quarter. Invesco Ltd. increased its stake in Globe Life by 2.7% in the 4th quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock worth $552,262,000 after acquiring an additional 102,445 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Globe Life by 10.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,353,192 shares of the company’s stock valued at $327,479,000 after acquiring an additional 217,331 shares in the last quarter. Morgan Stanley grew its holdings in shares of Globe Life by 7.2% during the fourth quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock worth $260,176,000 after purchasing an additional 125,567 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its holdings in shares of Globe Life by 32.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,435,247 shares of the company’s stock worth $200,734,000 after purchasing an additional 355,399 shares in the last quarter. Institutional investors own 81.61% of the company’s stock.

Globe Life News Summary

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Globe Life raised its FY 2026 net operating EPS guidance to $15.55-$15.95 and increased planned share repurchases to $670 million-$700 million, signaling management confidence and capital return support. Article
• Positive Sentiment: TD Cowen and JPMorgan both reiterated constructive views, with TD Cowen raising its price target to $225 and analysts forecasting meaningful upside from current levels. Article
• Neutral Sentiment: Q2 revenue came in at $1.60 billion, slightly above estimates, and underwriting income remained strong, helping offset some of the earnings disappointment. Article
• Neutral Sentiment: The company’s earnings call emphasized a mix of growth and headwinds, suggesting the business is still performing well operationally but faces pressure on sales and expenses. Article
• Negative Sentiment: Adjusted EPS of $3.61 missed the $3.67 consensus estimate, and several reports pointed to softer sales and rising expenses as the main reasons the stock sold off. Article

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.